Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
🇺🇸 FDA

trontinemab News

🇺🇸 Americas ← All news

FDA trontinemab coverage for business development, investment, and market access teams

Latest on trontinemab

Roche reports positive Phase 3 results for trontinemab in Alzheimer's disease
NewsAlzheimer's diseaseJun 7, 2026

Roche reports positive Phase 3 results for trontinemab in Alzheimer's disease

Roche reported positive Phase 3 results for trontinemab in early symptomatic Alzheimer's disease. ClinicalTrials.gov shows two recruiting Phase 3 studies and one earlier Phase 1/2 Brainshuttle AD study.

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.